Document ID: EPA-HQ-RCRA-2007-0932-0453
Agency: epa
Document Type: Supporting & Related Material
Title: 
Posted Date: 2019-02-22T05:00Z

EPA/HQ Summary  -  Meeting with Pharmaceutical Manufacturers

Attendees

Pfizer:		 	Richard Davis

Johnson & Johnson:	Phil Dahlin

Merck:			Jim Jahnke

Eli Lilly:		Neil Parke, Philip Shinn

Glaxo SmithKline:	Neal Parker

Sanofi:			Peter Wilson

Beveridge & Diamond: Don Patterson

EPA/HQ: 	Ross Elliott, Jessica Young, Kristin Fitzgerald, Ricardo Jones, Josh Smeraldi, Rachel Horton, Kathy Nam

Date:			February 25, 2016

Location:  		EPA/HQ  -  Potomac Yard

Summary

EPA HQ met with representatives of several pharmaceutical manufacturers and their outside counsel to discuss the Hazardous Waste Pharmaceuticals Proposed Rule.  

They confirmed that generic drugs do sometimes receive manufacturer credit, but dispensed drugs will not get credit.

They discussed that at the conclusion of clinical trials on new drugs, FDA requires manufacturers to account for all of the investigational drug.